Education
About Us
Working with TipRanks
Follow Us
PharmaTher Holdings Ltd (PHRRF)
OTHER OTC:PHRRF
Total Valuation
PharmaTher Holdings Ltd has a market cap or net worth of $6.66M. The enterprise value is $16.85M.
Market Cap$6.66M
Enterprise Value$16.85M
Share Statistics
PharmaTher Holdings Ltd has 91,019,066 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,019,066
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PharmaTher Holdings Ltd’s return on equity (ROE) is -1.57 and return on invested capital (ROIC) is -156.50%.
Return on Equity (ROE)-1.57
Return on Assets (ROA)-1.14
Return on Invested Capital (ROIC)-156.50%
Return on Capital Employed (ROCE)-1.57
Revenue Per Employee―
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PharmaTher Holdings Ltd is ―. PharmaTher Holdings Ltd’s PEG ratio is 0.20.
PE Ratio―
PS Ratio0.00
PB Ratio16.46
Price to Fair Value16.46
Price to FCF-13.24
Price to Operating Cash Flow-5.50
PEG Ratio0.20
Income Statement
In the last 12 months, PharmaTher Holdings Ltd had revenue of 0.00 and earned -1.53M in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit0.00
Operating Income-1.52M
Pretax Income-1.53M
Net Income-1.53M
EBITDA-1.52M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -1.11M and capital expenditures 3.00, giving a free cash flow of -1.11M billion.
Operating Cash Flow-1.11M
Free Cash Flow-1.11M
Free Cash Flow per Share-0.01
Dividends & Yields
PharmaTher Holdings Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.62
52-Week Price Change-50.00%
50-Day Moving Average0.09
200-Day Moving Average0.19
Relative Strength Index (RSI)43.14
Average Volume (3m)657.06K
Important Dates
PharmaTher Holdings Ltd upcoming earnings date is Jan 23, 2026, After Close (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateJan 23, 2026
Ex-Dividend Date―
Financial Position
PharmaTher Holdings Ltd as a current ratio of 3.11, with Debt / Equity ratio of 0.00%
Current Ratio3.11
Quick Ratio3.11
Debt to Market Cap0.00
Net Debt to EBITDA0.61
Interest Coverage Ratio0.00
Taxes
In the past 12 months, PharmaTher Holdings Ltd has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
PharmaTher Holdings Ltd EV to EBITDA ratio is -9.92, with an EV/FCF ratio of -12.48.
EV to Sales0.00
EV to EBITDA-9.92
EV to Free Cash Flow-12.48
EV to Operating Cash Flow-12.48
Balance Sheet
PharmaTher Holdings Ltd has $1.04M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.04M billion.
Cash & Marketable Securities$1.04M
Total Debt$0.00
Net Cash$1.04M
Net Cash Per Share$0.01
Tangible Book Value Per Share$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PharmaTher Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―